Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ALLERGAN, INC.
02/27 ALLERGAN : New Eyepowerment™ Campaign Urges The Up To 33 Million Americans..
02/26 INSIDER Q&A : Allergan CEO on impact of limiting price hikes
02/25 ALLERGAN : Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap
02/24 ALLERGAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
02/24 ALLERGAN : Considering Cosmetic Surgery? Try Asking Your Self Worth First
02/22 ALLERGAN : FlexJobs Identifies the Top 10 International Companies for Remote Job..
02/21 Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
02/17 Botulinum Toxins Market 2017 - Allergan, Ipsen, Merz, US WorldMeds, Medytox, ..
02/17 ALLERGAN : Health Companies Think Fat-Freezing Is the New Botox
02/14 ADVERUM BIOTECHNOLOGIES, INC. (NASDA : ADVM) Files An 8-K Departure of Directors..
02/14 ALLERGAN, INC. : Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence ..
02/14 ALLERGAN : to buy fat-fighting firm for $2.5bn
02/14 ALLERGAN : Acquires Zeltiq, The Makers of CoolSculpting
02/13 Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion
02/13 ZELTIQ AESTHETICS : Allergan to acquire Zeltiq and its 'CoolSculpting System' fo..
02/13 MARKETS RIGHT NOW : US indexes push to new all-time highs
02/13 Stada to hold takeover talks with rival suitors Cinven and Advent
02/13 MARKETS RIGHT NOW : US indexes open at record highs
02/13 ALLERGAN : to spend $2.48 B on CoolSculpting provider Zeltiq
02/13 US indexes open at record highs Monday
02/11 PFIZER : bounces back from Allergan setback by buying, buying, buying
02/11 ALLERGAN : Sara Shikhman Selected for Allergan's Brilliant Distinctions National..
02/09 ALLERGAN : eyes strong growth as it expects no US tax reform in 2017
02/08 Allergan says U.S. tax reform unlikely in 2017, sees strong year
02/08 ALLERGAN PLC (NYSE : AGN) Launches Campaign To Fight Preventable Blindness In Am..
02/08 ALLERGAN PLC (NYSE : AGN) Files An 8-K Results of Operations and Financial Condi..
02/08 ALLERGAN : reports 4Q loss
02/08 ALLERGAN PLC : Results of Operations and Financial Condition, Financial Statemen..
02/07 GLOBAL WELLNESS TOURISM INDUSTRY 201 : Accor, Allergan
02/07 TEVA PHARMACEUTICAL INDUSTRIES : Globes, Tel Aviv, Israel, Eli Tsipori column
02/07 ALLERGAN : Launches See America(SM), a Bold Initiative Furthering the Fight Agai..
02/03 ALLERGAN : Premier Beverly Hills Plastic Surgery Practice Will Be One of the Fir..
02/03 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
02/03 ALLERGAN PLC : Change in Directors or Principal Officers, Other Events (form 8-K..
02/02 IRONWOOD PHARMACEUTICALS : U.S. Food and Drug Administration Approves 72 mcg Dos..
02/02 SPECIAL NOTICE - 65--PROS-013117-886 : breast implants Urgent requestment for su..
02/02 SPECIAL NOTICE - 65-- PROS-013117-88 : breast implants Urgent requestment for su..
01/31 KCG : Acquires 29,538 Shares of Allergan Plc. (Agn)
01/31 ALLERGAN : Launches Juvederm Volite - an Innovative Injectable Treatment Designe..
01/27 ALLERGAN : Launches Juvéderm® Volite - an Innovative Injectable Treatment Design..
01/26 ALLERGAN : Teva faces further FTC claim
01/26 ALLERGAN : U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS® (l..
01/25 FDA APPROVES TRULANCE FROM SYNERGY P : SGYP) To Battle With Allergan Linzess
01/24 ALLERGAN : Dispatc hes
01/24 ALLERGAN : Dispatches
01/24 ALLERGAN : What Are Inversion Deals?
01/24 U.S. reaches settlement with Endo on pay-for-delay charges
01/23 ALLERGAN : Position Increased by Mitsubishi Ufj Trust & Banking Corp
01/20 ALLERGAN : Richter, Allergan sign distribution, supply agreement
01/19 ALLERGAN : Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride..
01/18 ALLERGAN : To pay $15m penalty over merger
01/17 Allergan to pay $15 million over failing to disclose merger talks
01/17 ALLERGAN : and Gedeon Richter Announce Positive Phase III Results for Ulipristal..
01/16 ALLERGAN : Big pharma establishes new industry standards group
01/16 ALLERGAN : Health care
01/10 ALLERGAN : Enters Licensing Agreement with Assembly Biosciences to Obtain Worldw..
01/10 ASSEMBLY BIOSCIENCES (NASDAQ : ASMB) Files An 8-K Entry into a Material Definiti..
01/09 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
01/09 ALLERGAN : continues to acquire companies with 2 more deals
01/08 ALLERGAN PLC (NYSE : AGN) Files An 8-K Departure of Directors or Certain Officer..
01/07 ALLERGAN : 11 Surprising Uses For Botox
01/06 ALLERGAN PLC : Change in Directors or Principal Officers (form 8-K)
01/06 Lori Lyons-Williams Joins Dermira as Chief Commercial Officer
01/05 ALLERGAN : FDA Approves Allergan’s NATRELLE INSPIRA SoftTouch Breast Impla..
01/04 ALLERGAN PLC (NYSE : AGN) Explodes After FDA Approval Of Natrelle Inspira
01/04 ABRAHAM, FRUCHTER & TWERSKY, LLP FIL : Agn)
01/02 ALLERGAN, INC. : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Inv..
2016 ALLERGAN, INC. : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses I..
2016 ALLERGAN, INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds ..
2016 ALLERGAN : picks up regenerative med company for $2.9B
2016 ALLERGAN : in $2.9B Aesthetics Buy
2016 ALLERGAN : buys regenerative medicine firm LifeCell for $2.9bn
2016 ALLERGAN : To Add Regenerative Medicine Company LifeCell Corp to Catalog in $2.9..
2016 ALLERGAN : buys regenerative medicine firm LifeCell for $2.9bn
2016 ALLERGAN, INC. : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class A..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON6.53%332 993
ROCHE HOLDING LTD.5.42%209 283
PFIZER INC.5.48%204 030
NOVARTIS AG4.72%203 039
MERCK & CO., INC.12.38%181 558
More Results